Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Jaundice	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
ERCP	O
(___)	O
History	O
of	O
Present	O
Illness:	O
HPI:	O
Pt	O
reports	O
1	O
week	O
of	O
darker	O
urine	O
(orange)	O
and	O
1	O
day	O
of	O
red	O
urine.	O
1	O
week	O
of	O
fatigue,	O
abdominal	O
discomfort	O
with	O
nausea	O
and	O
dry	O
heaving	O
over	O
the	O
week.	O
Denies	O
changes	O
in	O
stool.	O
In	O
the	O
ED,	O
initial	O
vitals	O
were:	O
98.2	O
88	O
149/89	O
18	O
97%	O
RA	O
Exam	O
notable	O
for:Scleral	O
iceterus,	O
No	O
abd	O
pain,	O
neg	O
___	O
sign	O
Mild	O
___	O
bilateral	O
Labs	O
notable	O
for:	O
UA	O
with	O
4	O
urobil,	O
large	O
bili,	O
80	O
ketones,	O
few	O
bacteria.	O
Icteric	O
serum	O
with	O
AST/ALT	O
146/186	O
AP	O
277	O
Tbili	O
9.7.	O
WBC	O
7.6	O
H/H	O
13.5/40.5	O
Plt	O
244	O
Imaging	O
notable	O
for:	O
OSH	O
RUQ	O
and	O
CT	O
abd/pelv	O
reports	O
in	O
chart,	O
notable	O
for	O
CBD	O
9mm,	O
cholelithiasis	O
Patient	O
was	O
given:	O
nothing	O
ERCP	O
consulted	O
and	O
recommended:	O
ERCP	O
in	O
AM	O
Vitals	O
prior	O
to	O
transfer:	O
98.1	O
67	O
128/65	O
16	O
98%RA	O
On	O
the	O
floor,	O
pt	O
is	O
without	O
complaint,	O
though	O
endorses	O
prior	O
nausea	O
and	O
dry	O
heaving	O
prior	O
to	O
transfer.	O
ROS:	O
(+)	O
Per	O
HPI	O
(-)	O
Denies	O
fever,	O
chills,	O
night	O
sweats,	O
recent	O
weight	B-Weight_loss
loss	B-Weight_loss
or	O
gain.	O
Denies	O
headache,	O
sinus	O
tenderness,	O
rhinorrhea	O
or	O
congestion.	O
Denies	O
cough,	O
shortness	O
of	O
breath.	O
Denies	O
chest	O
pain	O
or	O
tightness,	O
palpitations.	O
Denies	O
diarrhea,	O
constipation.	B-Constipation
No	O
recent	O
change	O
in	O
bowel	O
or	O
bladder	O
habits.	O
No	O
dysuria.	O
Denies	O
arthralgias	O
or	O
myalgias	O
Past	O
Medical	O
History:	O
COPD	O
Thyroid	O
nodules,	O
negative	O
biopsy	O
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
died	O
MI	O
at	O
___	O
Mother:	O
died	O
lung	O
cancer	O
Brother:	O
died	O
lung	O
cancer	O
recently	O
age	O
___	O
2	O
daughters,	O
healthy	O
6	O
grandchildren,	O
healthy	O
Physical	O
Exam:	O
ON	O
ADMISSION:	O
PHYSICAL	O
EXAM:	O
Vital	O
Signs:	O
98.2	O
154/77	O
73	O
18	O
97%RA	O
General:	O
Alert,	O
oriented,	B-Delirium
no	O
acute	O
distress	O
HEENT:	O
Sclera	O
icteric,	O
MMM	O
with	O
jaundiced	O
MM,	O
oropharynx	O
clear,	O
EOMI,	O
PERRL,	O
neck	O
supple,	O
JVP	O
not	O
elevated,	O
no	O
LAD	O
CV:	O
Regular	O
rate	O
and	O
rhythm,	O
normal	O
S1	O
+	O
S2,	O
no	O
murmurs,	O
rubs,	O
gallops	O
Lungs:	O
Clear	O
to	O
auscultation	O
bilaterally,	O
no	O
wheezes,	O
rales,	O
rhonchi	O
Abdomen:	O
Soft,	O
non-tender,	O
non-distended,	O
bowel	O
sounds	O
present,	O
no	O
organomegaly,	O
no	O
rebound	O
or	O
guarding	O
GU:	O
No	O
foley	O
Ext:	O
Warm,	O
well	O
perfused,	O
2+	O
pulses,	O
no	O
clubbing,	O
cyanosis	O
or	O
edema	O
Neuro:	O
CNII-XII	O
intact,	O
___	O
strength	O
upper/lower	O
extremities,	O
grossly	O
normal	O
sensation,	O
2+	O
reflexes	O
bilaterally,	O
gait	O
deferred.	O
ON	O
DISCHARGE:	O
Physical	O
Exam:	O
Vitals-	O
98.2	O
___	O
98%	O
on	O
RA	O
General-	O
Pleasant	O
elderly	O
male	O
laying	O
in	O
bed	O
in	O
NAD	O
HEENT-	O
Sclera	O
icteric,	O
improved	O
from	O
before,	O
EOMI.	O
PERRL.	O
MMM.	O
Clear	O
oropharynx.	O
Neck	O
supple.	O
No	O
LAD	O
Lungs-	O
Clear	O
to	O
auscultation	O
bilaterally,	O
no	O
wheezes,	O
rales,	O
rhonchi	O
CV-	O
Regular	O
rate	O
and	O
rhythm,	O
normal	O
S1	O
+	O
S2,	O
no	O
murmurs,	O
rubs,	O
gallops	O
Abdomen-	O
soft,	O
non-tender,	O
non-distended,	O
bowel	O
sounds	O
present.	O
No	O
organomegaly.	O
GU-	O
no	O
foley	O
Ext-	O
warm,	O
well	O
perfused,	O
2+	O
pulses,	O
no	O
clubbing,	O
cyanosis	O
or	O
edema	O
Neuro-	O
CNII-XII	O
intact,	O
motor	O
function	O
grossly	O
normal.	O
AOx3	B-Dementia
Pertinent	O
Results:	O
ON	O
ADMISSION:	O
___	O
07:02PM	O
___	O
PTT-28.8	O
___	O
___	O
07:02PM	O
PLT	O
COUNT-244	O
___	O
07:02PM	O
NEUTS-67.3	O
LYMPHS-18.7*	O
MONOS-7.7	O
EOS-5.0	O
BASOS-0.9	O
IM	O
___	O
AbsNeut-5.10	O
AbsLymp-1.42	O
AbsMono-0.58	O
AbsEos-0.38	O
AbsBaso-0.07	O
___	O
07:02PM	O
WBC-7.6	O
RBC-4.57*	O
HGB-13.5*	O
HCT-40.5	O
MCV-89	O
MCH-29.5	O
MCHC-33.3	O
RDW-12.9	O
RDWSD-41.9	O
___	O
07:02PM	O
ALBUMIN-3.9	O
___	O
07:02PM	O
LIPASE-33	O
___	O
07:02PM	O
ALT(SGPT)-186*	O
AST(SGOT)-146*	O
ALK	O
PHOS-277*	O
TOT	O
BILI-9.7*	O
DIR	O
BILI-7.9*	O
INDIR	O
BIL-1.8	O
___	O
07:02PM	O
GLUCOSE-96	O
UREA	O
N-16	O
CREAT-0.7	O
SODIUM-143	O
POTASSIUM-3.7	O
CHLORIDE-106	O
TOTAL	O
CO2-24	O
ANION	O
GAP-17	O
___	O
07:40PM	O
URINE	O
BLOOD-NEG	O
NITRITE-NEG	O
PROTEIN-TR	O
GLUCOSE-NEG	O
KETONE-80	O
BILIRUBIN-LG	O
UROBILNGN-4*	O
PH-6.0	O
LEUK-NEG	O
NOTABLE	O
LABS	O
___	O
07:02PM	O
BLOOD	O
ALT-186*	O
AST-146*	O
AlkPhos-277*	O
TotBili-9.7*	O
DirBili-7.9*	O
IndBili-1.8	O
___	O
05:31AM	O
BLOOD	O
ALT-193*	O
AST-149*	O
LD(LDH)-192	O
AlkPhos-265*	O
TotBili-10.2*	O
___	O
04:57AM	O
BLOOD	O
ALT-200*	O
AST-161*	O
AlkPhos-237*	O
TotBili-5.8*	O
___	O
05:20AM	O
BLOOD	O
ALT-237*	O
AST-164*	O
AlkPhos-221*	O
TotBili-3.8*	O
___	O
05:35AM	O
BLOOD	O
ALT-212*	O
AST-118*	O
AlkPhos-203*	O
TotBili-2.7*	O
ON	O
DISCHARGE:	O
___	O
05:35AM	O
BLOOD	O
Calcium-8.8	O
Phos-2.8	O
Mg-1.8	O
___	O
05:35AM	O
BLOOD	O
ALT-212*	O
AST-118*	O
AlkPhos-203*	O
TotBili-2.7*	O
___	O
05:35AM	O
BLOOD	O
Glucose-109*	O
UreaN-19	O
Creat-0.8	O
Na-140	O
K-4.1	O
Cl-101	O
HCO3-30	O
AnGap-13	O
___	O
05:35AM	O
BLOOD	O
Plt	O
___	O
___	O
05:35AM	O
BLOOD	O
WBC-6.4	O
RBC-4.33*	O
Hgb-12.9*	O
Hct-38.3*	O
MCV-89	O
MCH-29.8	O
MCHC-33.7	O
RDW-13.1	O
RDWSD-42.2	O
Plt	O
___	O
IMAGING:	O
MRCP	O
___:	O
IMPRESSION:	O
1.	O
No	O
choledocholithiasis	O
or	O
focal	O
pancreatic	O
mass.	O
2.	O
The	O
cystic	O
duct	O
inserts	O
very	O
low	O
on	O
the	O
common	O
hepatic	O
duct,	O
at	O
the	O
level	O
of	O
the	O
pancreatic	O
head.	O
3.	O
Mild	O
left	O
hepatic	O
lobe	O
biliary	O
ductal	O
dilatation	O
persists.	O
No	O
obstructing	O
lesion	O
detected.	O
Pneumobilia	O
is	O
likely	O
related	O
to	O
reported	O
recent	O
ERCP.	O
4.	O
Cholelithiasis,	O
including	O
a	O
1.4	O
cm	O
gallbladder	O
neck	O
stone,	O
without	O
evidence	O
of	O
cholecystitis.	O
5.	O
Subcentimeter	O
pancreatic	O
tail	O
cystic	O
lesions	O
likely	O
reflect	O
side	O
branch	O
IPMNs.	O
Given	O
lesion	O
size	O
and	O
patient	O
age,	O
recommend	O
pancreatic	O
cyst	O
follow-up	O
MRI	O
in	O
___	O
year.	O
6.	O
3.4	O
cm	O
right	O
adrenal	O
adenoma.	O
7.	O
Mild	O
hepatic	O
steatosis.	O
8.	O
Trace	O
right	O
pleural	O
effusion.	O
RECOMMENDATION(S):	O
Subcentimeter	O
pancreatic	O
tail	O
cystic	O
lesions	O
likely	O
reflect	O
side	O
branch	O
IPMNs.	O
Given	O
lesion	O
size	O
and	O
patient	O
age,	O
recommend	O
pancreatic	O
cyst	O
follow-up	O
MRI	O
in	O
___bd/Pelv	O
wo	O
contrast	O
___	O
Impression:	O
1.	O
Cholelithiasis	O
2.	O
Apparent	O
biliary	O
duct	O
dilation	O
in	O
the	O
left	O
lobe	O
of	O
the	O
liver.	O
A	O
central	O
obstructing	O
mass	O
is	O
not	O
excluded.	O
Correlation	O
with	O
the	O
liver	O
function	O
tests	O
could	O
be	O
helpful.	O
A	O
contrast-enhanced	O
MRCP	O
is	O
recommended	O
if	O
the	O
finding	O
has	O
not	O
been	O
previously	O
evaluated.	O
3.	O
No	O
nephrolithiasis	O
or	O
explanation	O
for	O
the	O
hematuria.	O
OSH	O
RUQ	O
U/S	O
___	O
Impression:	O
1.	O
Dilated	O
intrahepatic	O
biliary	O
ducts	O
and	O
common	O
bile	O
duct.	O
Again	O
an	O
MRCP	O
with	O
contrast	O
is	O
recommended.	O
2.	O
Cholelithiasis	O
and	O
equivocal	O
gallbladder	O
wall	O
thickening.	O
A	O
HIDA	O
scan	O
could	O
be	O
performed	O
if	O
there	O
is	O
clinical	O
evidence	O
of	O
acute	O
cholecystitis.	O
If	O
not,	O
the	O
possible	O
gallbladder	O
wall	O
thicvkening	O
can	O
be	O
evaluated	O
at	O
the	O
time	O
of	O
the	O
MRCP.	O
OSH	O
CXR	O
___	O
(AP	O
Portable)	O
Impression:	O
1.	O
Cardiomegaly	O
Brief	O
Hospital	O
Course:	O
___	O
year	O
old	O
man	O
with	O
mild	O
COPD	O
otherwise	O
healthy	O
presents	O
with	O
darkening	O
urine	O
and	O
jaundice	O
concerning	O
for	O
obstructive	O
jaundice	O
with	O
T.bili	O
~10s.	O
#Jaundice,	O
CBD	O
dilation	O
Patient's	O
symptoms	O
and	O
bilirubin	O
consistent	O
with	O
obstructive	O
jaundice.	O
CT	O
abd/pelvis	O
and	O
RUQ	O
ultrasound	O
revealing	O
biliary	O
duct	O
dilation	O
and	O
cholelithiasis.	O
Patient	O
underwent	O
ERCP,	O
which	O
revealed	O
a	O
filling	O
defect	O
(stone	O
vs	O
tumor)	O
in	O
the	O
middle	O
third	O
of	O
the	O
biliary	O
tree.	O
Brush	O
cytology	O
samples	O
were	O
collected	O
of	O
the	O
main	O
duct	O
and	O
common	O
bile	O
duct	O
was	O
stented,	O
which	O
resolved	O
patient's	O
symptoms	O
correlating	O
with	O
downtrending	O
t.	O
bilirubin.	O
Patient	O
given	O
IF	O
fluids	O
and	O
was	O
NPO,	O
then	O
advanced	O
to	O
BRAT	O
diet	O
to	O
prevent	O
post-ERCP	O
pancreatitis.	O
MRCP	O
was	O
done	O
afterwards,	O
revealing	O
no	O
malignant	O
biliary	O
or	O
pancreatic	O
mass,	O
but	O
a	O
1.4cm	O
gallstone	O
in	O
the	O
neck	O
of	O
the	O
bladder	O
and	O
subcentimeter	O
intraductal	O
papillary	O
mucinous	O
neoplasms	O
with	O
recommended	O
repeat	O
MRCP	O
imaging	O
in	O
a	O
year.	O
Suspect	O
that	O
patient	O
may	O
have	O
had	O
intermittent	O
choledocholithiasis	O
and	O
we	O
recommend	O
that	O
patient	O
have	O
elective	O
cholecystectomy.	O
Patient	O
was	O
stable	O
for	O
discharge,	O
tolerating	O
PO	O
well.	O
#COPD:	O
20	O
pack	O
year	O
smoking	O
history.	O
COPD	O
was	O
stable.	O
Foradil	O
not	O
on	O
formulary,	O
so	O
patient	O
was	O
given	O
salmeterol	O
BID,	O
duo-nebs	O
PRN	O
for	O
SOB	O
TRANSITIONAL	O
ISSUES:	O
======================	O
[]	O
___	O
CBD	O
brushings	O
from	O
ERCP,	O
pathology	O
pending	O
at	O
discharge	O
[]	O
___	O
appointment	O
ERCP	O
in	O
4	O
weeks	O
[]	O
elective	O
outpatient	O
cholecystectomy	O
recommended	O
for	O
cholelithiasis	O
[]	O
repeat	O
LFTs	O
at	O
PCP	O
___,	O
downtrending	O
after	O
stent	O
placement	O
#	O
CODE:	O
Full,	O
confirmed	O
#	O
CONTACT:	O
___	O
(wife)	O
___	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Foradil	O
Aerolizer	O
(formoterol	O
fumarate)	O
12	O
mcg	O
inhalation	O
BID	O
Discharge	O
Medications:	O
1.	O
Foradil	O
Aerolizer	O
(formoterol	O
fumarate)	O
12	O
mcg	O
inhalation	O
BID	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
PRIMARY:	O
Obstructive	O
Jaundice	O
SECONDARY:	O
chronic	O
obstructive	O
pulmonary	O
disease	O
intraductal	O
papilloma	O
mucinous	O
neoplasm	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Dear	O
Mr.	O
___,	O
You	O
were	O
admitted	O
because	O
you	O
were	O
complaining	O
of	O
darkening	O
urine	O
and	O
found	O
to	O
be	O
jaundiced	O
because	O
there	O
was	O
an	O
obstruction	O
in	O
your	O
bile	O
duct.	O
You	O
underwent	O
a	O
procedure	O
called	O
ERCP	O
(Endoscopic	O
retrograde	O
cholangiopancreatography)	O
where	O
they	O
took	O
brushing	O
samples	O
of	O
your	O
biliary	O
duct	O
and	O
placed	O
a	O
stent	O
in	O
your	O
common	O
bile	O
duct	O
which	O
resolved	O
your	O
jaundice.	O
You	O
also	O
got	O
an	O
MRI	O
of	O
your	O
pancreatic	O
and	O
biliary	O
system	O
which	O
revealed	O
a	O
gallstone	O
as	O
well	O
as	O
a	O
cyst	O
of	O
the	O
pancreatic	O
duct	O
called	O
intraductal	O
papillary	O
mucinous	O
neoplasm	O
(IPMN).	O
We	O
suspect	O
that	O
gallstones	O
caused	O
an	O
obstruction	O
leading	O
to	O
your	O
symptoms,	O
but	O
might	O
have	O
passed	O
before	O
you	O
got	O
the	O
ERCP.	O
In	O
2	O
weeks,	O
you	O
can	O
call	O
the	O
GI	O
doctors	O
to	O
follow	O
up	O
the	O
results	O
of	O
your	O
brughings.	O
In	O
4	O
weeks,	O
you	O
should	O
have	O
a	O
repeat	O
ERCP	O
to	O
re-evaluate	O
your	O
biliary	O
system	O
and	O
to	O
take	O
out	O
the	O
stent.	O
Afterwards,	O
we	O
recommend	O
that	O
you	O
get	O
your	O
gallbladder	O
removed	O
by	O
surgery.	O
You	O
should	O
also	O
have	O
a	O
repeat	O
MRCP	O
in	O
a	O
year	O
to	O
follow	O
up	O
the	O
IPMN.	O
We	O
wish	O
you	O
the	O
best,	O
Your	O
___	O
team	O
Followup	O
Instructions:	O
___	O

